Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Vascular endothelial growth factor receptor 2 (KDR) |
Target Info
|
Modulator |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT01105533) A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors. U.S. National Institutes of Health.
|
| REF 2 |
Inhibition of VEGFR-2 Reverses Type 1 Diabetes in NOD Mice by Abrogating Insulitis and Restoring Islet Function. Diabetes. 2013 August; 62(8): 2870-2878.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
